Palo Alto and Gunn High School education councils, which are made up of teachers and staff, declined to offer Multivariable Calculus as a high school course, instead opting to pick up a newly ...

SAN FRANCISCO – Jonathan Kuminga is skilled and talented, a basketball superstar-in-waiting who is being subjected to malicious detention by his employers. Once liberated from the Warriors, he will be ...

UW-Madison researchers have found potential new treatments for a rare pediatric brain cancer each year that has a median survival time of less than a year. The research involved thousands of fruit ...

The Cleveland Browns are officially moving on from Kevin Stefanski as head coach, the team announced earlier this morning. Stefanski led the Browns through a lot of happy times, along with some low ...

KYIV—When the U.S. rolled out its 28-point Ukraine peace plan this fall, leaders in Kyiv saw a series of traps laid by the Kremlin. The document, which was devised with Russian input, included points ...

The Palo Alto Board of Education has unanimously approved a multivariable calculus course. Weekly file photo by Veronica Weber. The Palo Alto Board of Education unanimously approved two new advanced ...

ORLANDO — It was a quiet week at the winter meetings for the Guardians, but at least they didn’t go home empty handed. On Wednesday, they selected right-hander Peyton Pallette from the White Sox’s ...

It has not always been smooth sailing for the North Carolina Tar Heels' offensive production this season, but the team has identified a way to generate consistent points. During the last two weeks, ...

Yesterday, we released our first batch of mock Giannis Antetokounmpo trades. These deals were meant to cover the most frequently discussed trade partners: the big markets like New York, Los Angeles ...

It was all treats and no tricks on Tuesday's Halloween episode of "High Potential," which ended with the only thing better than a candy haul — we finally got a peek inside Roman's backpack! At the top ...

Arcus Biosciences boasts a diverse, promising pipeline with key candidates like domvanalimab, casdatifan, and quemliclustat advancing in pivotal trials. Recent data from RCUS's EDGE-Gastric trial show ...